netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 8 of 8


Details
LDL Link Added : MHRA Drug Safety Update (Apr 2016): Natalizumab (Tysabri▼): progressive multifocal leukoencephalopathy— updated advice to support early detection : https://www.gov.uk/drug-safety-update/natalizumab-tysabri-progressive-multifocal-leukoen
06/07/2023 11:52:07
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (May 2011): Natalizumab (Tysabri▼): risk of progressive multifocal leukoencephalopathy is increased in patients who have had previous immunosuppressant treatment : https://www.gov.uk/drug-safety-update/natalizuma
06/07/2023 11:51:39
(rpaylor )
UPD Natalizumab updated
10/05/2018 10:03:20
(DavidS )
UPD Natalizumab DHS
22/02/2018 09:12:21
(DavidS )
UPD Natalizumab b
01/02/2017 16:14:51
(DavidS )
LDL Link Added : Disease Modifying Therapies for Patients with Multiple Sclerosis (MS) : https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2013/10/d04-p-b.pdf
24/01/2017 16:21:00
(WhitehallJ )
UPD Natalizumab b
24/01/2017 16:20:33
(WhitehallJ )
UPD Natalizumab (Tysabri®) build
29/11/2016 09:00:58
(DavidS )

 

 

netFormulary